![Anand Patel: Enjoyed reading this analysis of HMA-VEN and IC in patients ≥ 60 years old with newly-diagnosed IDHm AML](https://oncodaily.com/pub/uploads/2024/05/Снимок-экрана-2024-05-20-213355-1-1280x430.png)
Photo from onlinelibrary.wiley.com
May 22, 2024, 06:24
Anand Patel: Enjoyed reading this analysis of HMA-VEN and IC in patients ≥ 60 years old with newly-diagnosed IDHm AML
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared on X/Twitter:
“Enjoyed reading this analysis of HMA-VEN and IC in patients ≥60 years old with newly-diagnosed IDHm AML led by Shai Shimony, Maximilian Stahl, Rory M. Shallis et al.
-151 pt (81 IC 70 HMA-VEN)
-cCR rate 67% for both groups
-2y OS 45% for cohort (51% for IC, 35% for HMA-VEN p=0.14).”
Source: Anand Patel/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 4, 2024, 11:31